Condition: Coronary Artery Disease · Sponsor: PlaqueTec Ltd
The aim of this research, proposed and funded by PlaqueTec and co-ordinated by Papworth Trials Unit Collaboration, is to demonstrate the performance of the coronary artery blood sampling device (Liquid Biospy System, LBS) and establish its usefulness to collect a range of disease biomolecules from the coronary artery of interest. Using the data generated from extensive analysis of the blood samples, key biomarker data will be generated that will close a knowledge gap and facilitate the development of tailored treatments for coronary artery disease.
This description comes directly from the study's public registry record.
Clinical Project Manager · 01223638000 · papworth.biopattern@nhs.net
PlaqueTec General Manager · simon@plaquetec.com
Always discuss trial participation with your own doctor first.
| Royal Bournemouth Hospital | Bournemouth, United Kingdom | Recruiting |
| Bristol Heart Institute | Bristol, United Kingdom | Recruiting |
| Royal Papworth Hospital | Cambridge, United Kingdom | Recruiting |
| Norfolk and Norwich Hospital | Norwich, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06259019